Vantage Market Research
Oct 03, 2024
Vantage Market Research releases its latest comprehensive report on the ‘Global Enteral Feeding Devices Market’ with a forecast period of 2025-2034. In 2023, the global enteral feeding devices market size was USD 4.46 billion, and is calculated at USD 4.2 billion in 2024. The market is projected to reach USD 8.06 billion in 2034, and register a revenue CAGR of 6.1% over the forecast period (2025-2034).
Market Overview:
The global enteral feeding devices market has been registering steady and inclining revenue growth, with a number of factors expected to continue to support the upward trajectory over the forecast period. Increasing aging population, rising prevalence of various chronic diseases and conditions, age-related conditions and disorders, stroke, Alzheimer’s, Parkinson’s Disease (PD), Attention-Deficit/Hyperactivity Disorder (ADHD), osteoporosis, osteoarthritis, Gastrointestinal (GI) diseases, non-GI diseases, increasing rate of preterm births worldwide, and steady use of these devices in critical care, along with increasing rate of surgeries are some key factors driving market revenue growth. Demand for enteral feeding devices from hospitals and long-term care facilities has been rising, and demand for these products through care services in home care settings has also risen significantly since 2020. Demand from pediatric and geriatric patient populations also remains steady, with this trend expected to maintain momentum over the forecast period.
Technological advancements are also playing a major role in driving adopting, preference, and use of various products in the market. Development and introduction of smart enteral feeding devices and pumps that enable more precise and real-time monitoring and administering of nutrients and medications, and increasing awareness regarding use of antimicrobial materials and safety and risk reduction of these materials are factors also having a positive impact on market growth.
High rate of preterm births is also supporting market growth. According to World Health Organization (WHO), the United Nations Children’s Fund (UNICEF), the London School of Hygiene and Tropical Medicine, and study published in the Lancet medical journal, one in all 10 live births or 13.4 million infants were born premature in 2020. Premature infants are unable to suckle effectively and require enteral feeding devices such as feeding tube, to address nutritional needs. Also, the nutritional needs of premature infants is higher compared to full-term babies, and feeding tubes are used to deliver specialized formulas directly into the digestive tract. Birthrates of preterm infants directly corelates with demand for enteral feeding devices and systems, and as the trend is global, is a major factor coupled with advancements in the healthcare sector that are expected to continue to drive steady market revenue growth.
Demand for wireless enteral feeding devices has been rising in ambulatory and home care settings due to ability to communicate with various information systems such as Electronic Medical Record (EHR), allowing for safer and more accurate medication delivery, particularly in pediatric intensive care units (ICUs) and Neonatal Intensive Care Units (NICUs). These devices enable streamlining of workflows, reduces treatment costs, and minimizes errors, thereby easing workload for healthcare professionals.
Technological advancements and innovations in medical devices and systems is another major factor driving growth of this market. Emergence of innovative enteral feeding devices and smart pumps with advanced control, connectivity, and monitoring capabilities, and use of antimicrobial materials with reduced risks of infection to patient. These innovations are also enabling increasing number of individuals being cared for in home care settings to leverage convenience and comfort of being among family, and also ensures adequate and appropriate care.
However, enteral feeding devices can be costly, and cost can multiply over long-term or as per patient need. Besides initial costs for devices, regular maintenance costs can also add up. Reimbursement policies, especially in some economies, may not cover some expenses in full, and this can be a burden to healthcare systems. Also, enteral feeding can cause complications to patient in the form of tube displacement, aspiration pneumonia, or infection. These factors can have a negative impact on preferences among some patients, thereby resulting in opting for alternative approaches to nutrition or drug intake. Another factor having negative impact on market growth is approval for new products and systems can be lengthy and incur additional costs as well as delay time to market. Stringent regulatory standards and requirements can also prove challenging to navigate and can have some impact on manufacturers and healthcare providers.
Some Key Takeaways:
- North America enteral feeding devices market accounted for largest revenue share in 2023, and the trend is expected to continue.
- Europe accounted for significantly large revenue share in 2023, with Germany, the UK, and France accounting for major revenue shares respectively.
- Asia Pacific registered fastest revenue growth rate in 2023, with China, Japan, and India accounting for major revenue share contribution.
- The feeding tubes segment is expected to continue to account for majority revenue share over the forecast period.
- The adult segment among the age group segments is expected to continue to account for largest revenue share over the forecast period, driven by factors such as aging population and age-related diseases and conditions, and rising prevalence of chronic diseases.
- The oncology segment is expected to continue to account for largest revenue share over the forecast period, driven by rising prevalence of different types of cancer.
- Among the end-user segments, the hospitals and clinics segment is expected to maintain its dominance in terms of revenue share contribution to the global enteral feeding devices over the forecast period.
- The competitive landscape in the global enteral feeding devices market is dynamic, with a number of leading companies deploying various strategies and innovations with focus on expanding consumer base and leveraging maximum revenue share.
Company List:
• Conmed Corporation
• C.R.Bard
• Cook Medical
• Boston Scientific Corporation
• Moog Inc.
• Fresenius Kabi AG
• Danone Medical Nutrition
• Kimberly-Clark
• Abbott Nutrition
• B Braun Melsungen AG
• Avanos Medical, Inc.
• Cardinal Health
• Applied Medical Technology, Inc.
• Vygon India
• Fidmi Medical
Recent Developments:
•May 8, 2024: Rockfield Medical Devices Limited announced securing U.S. Food and Drug Administration (FDA) 510(k) Over the Counter Clearance (OTC) of its Mobility+ Enteral Feeding System. With this development, Rockfield Medical Devices, which is a commercial-stage medical device company focused on developing solutions to transform the mobility and quality of life of tube feeders, can market its system through OTC in the US. The new system is a portable, lightweight, elastomeric, enteral feeding system that delivers liquid nutrition formula to an enteral access device (feeding tube) in users aged two years and over, in clinical or home care settings, and is designed for single patient use and can be used over a 24-hour period.
•September 28, 2023: Cardinal Health announced launch of Kangaroo OMNI Enteral Feeding Pump in the US. This device is designed for enteral feeding with some personalized feeding options to support patient-specific requirements. The Kangaroo OMNI can operate independently of orientation, delivers thick, homogenized, and blended formulas, and is highly portable due to compact design and lightweight. The device also supports 19 languages for on-screen content, and this positions it in high appeal among users across the globe.